RhAPPcast: Navigating the Complexities: IL-17 Inhibitors and IBD Risk

In this episode of RhAPPcast, host Amanda Mixon, PA-C, dives into the complexities of IL-17 inhibitors and their association with inflammatory bowel disease (IBD). Joined by Candace Ryan, a seasoned rheumatology expert, they explore the benefits and risks of IL-17 therapy for rheumatic patients. Tune in to gain insights into current evidence, clinical trials, and best practices for managing these therapies.